{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:02:48Z","timestamp":1778565768459,"version":"3.51.4"},"reference-count":34,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2011]]},"DOI":"10.1620\/tjem.223.153","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T06:06:44Z","timestamp":1298441204000},"page":"153-159","source":"Crossref","is-referenced-by-count":40,"title":["Calcitriol Treatment Attenuates Inflammation and Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism"],"prefix":"10.1620","volume":"223","author":[{"given":"Chia-Chao","family":"Wu","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Hung","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Chi-Mei Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Chi","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Bin","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Chi-Mei Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai-King","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ya","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Mei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Kuang","family":"Diang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Cheng","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Alexiewicz, J.M., Klinger, M., Pitts, T.O., Gaciong, Z., Linker-Israeli, M. &amp; Massry, S.G. (1990) Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure. <i>J. Am. Soc. Nephrol<\/i>., <b>1<\/b>, 236-244.","DOI":"10.1681\/ASN.V13236"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Andress, D.L. (2008) Bone and mineral guidelines for patients with chronic kidney disease: a call for revision. <i>Cli. J. Am. Soc. Nephrol<\/i>., <b>3<\/b>, 179-183.","DOI":"10.2215\/CJN.01310307"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Autier, P. &amp; Gandini, S. (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. <i>Arch. Intern. Med<\/i>., <b>167<\/b>, 1730-1737.","DOI":"10.1001\/archinte.167.16.1730"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011629"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(86)90291-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Bhan, I. &amp; Thadhani, R. (2009) Vitamin D therapy for chronic kidney disease. <i>Semin. Nephrol<\/i>., <b>29<\/b>, 85-93.","DOI":"10.1016\/j.semnephrol.2008.10.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Biggar, P.H., Liangos, O., Fey, H., Brandenburg, V.M. &amp; Ketteler, M. (2011) Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug? <i>Pediatr. Nephrol<\/i>., <b>26<\/b>, 7-18.","DOI":"10.1007\/s00467-010-1526-x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Boonstra, A., Barrat, F.J., Crain, C., Heath, V.L., Savelkoul, H.F. &amp; O'Garra, A. (2001) 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. <i>J. Immunol<\/i>., <b>167<\/b>, 4974-4980.","DOI":"10.4049\/jimmunol.167.9.4974"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Chhokar, V.S., Sun, Y., Bhattacharya, S.K., Ahokas, R.A., Myers, L.K., Xing, Z., Smith, R.A., Gerling, I.C. &amp; Weber, K.T. (2005) Hyperparathyroidism and the calcium paradox of aldosteronism. <i>Circulation<\/i>., <b>111<\/b>, 871-878.","DOI":"10.1161\/01.CIR.0000155621.10213.06"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Fraser, W.D. (2009) Hyperparathyroidism. <i>Lancet<\/i>, <b>374<\/b>, 145-158.","DOI":"10.1016\/S0140-6736(09)60507-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Gal-Moscovici, A. &amp; Sprague, S.M. (2010) Use of vitamin D in chronic kidney disease patients. <i>Kidney Int<\/i>., <b>78<\/b>, 146-151.","DOI":"10.1038\/ki.2010.113"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Geara, A.S., Castellanos, M.R., Bassil, C., Schuller-Levis, G., Park, E., Smith, M., Goldman, M. &amp; Elsayegh, S. (2010) Effects of parathyroid hormone on immune function. <i>Clin. Dev. Immunol<\/i>., <b>2010<\/b>, 418695.","DOI":"10.1155\/2010\/418695"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00118.x"},{"key":"14","unstructured":"Kaneko, T., Osono, E., Hayama, N., Lino, Y. &amp; Terashi, A. (1997) T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease. <i>Clin. Nephrol<\/i>., <b>48<\/b>, 353-358."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Kosch, M., Hausberg, M., Vormbrock, K., Kisters, K., Rahn, K.H. &amp; Barenbrock, M. (2000) Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. <i>Am. J. Hypertens<\/i>., <b>13<\/b>, 759-764.","DOI":"10.1016\/S0895-7061(00)00248-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Lu, K.C., Tseng, C.F., Wu, C.C., Yeung, L.K., Chen, J.S., Chao, T.Y., Janckila, A.J., Yam, L.T. &amp; Chu, P. (2006) Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism. <i>Blood Purif.<\/i>, <b>24<\/b>, 423-430.","DOI":"10.1159\/000094899"},{"issue":"11","key":"17","first-page":"5827","volume":"46","year":"1986","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Melamed, M.L., Eustace, J.A., Plantinga, L., Jaar, B.G., Fink, N.E., Coresh, J., Klag, M.J. & Powe, N.R. (2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. <i>Kidney Int<\/i>., <b>70<\/b>, 351-357.","DOI":"10.1038\/sj.ki.5001542"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Melamed, M.L., Michos, E.D., Post, W. &amp; Astor, B. (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. <i>Arch. Intern. Med<\/i>., <b>168<\/b>, 1629-1637.","DOI":"10.1001\/archinte.168.15.1629"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Moe, S.M., Zekonis, M., Harezlak, J., Ambrosius, W.T., Gassensmith, C.M., Murphy, C.L., Russell, R.R. &amp; Batiuk, T.D. (2001) A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol. <i>Am. J. Kidney Dis<\/i>., <b>38<\/b>, 792-802.","DOI":"10.1053\/ajkd.2001.27697"},{"key":"21","unstructured":"Muller, K. &amp; Bendtzen, K. (1996) 1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions. <i>J. Investig. Dermatol. Symp. Proc<\/i>., <b>1<\/b>, 68-71."},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1210\/er.2004-0002"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Patel, T.V. &amp; Singh, A.K. (2009a) Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions. <i>Semin. Nephrol<\/i>., <b>29<\/b>, 105-112.","DOI":"10.1016\/j.semnephrol.2009.01.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Patel, T.V. &amp; Singh, A.K. (2009b) Role of vitamin D in chronic kidney disease. <i>Semin. Nephrol<\/i>., <b>29<\/b>, 113-121.","DOI":"10.1016\/j.semnephrol.2009.01.004"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1126\/science.6310748"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Rodriguez-Garcia, M., Fernandez-Martin, J.L., De, C.J.R., Hervas-Sanchez, J. &amp; Cannata-Andia, J.B. (2003) Advantages of adjusting the initial dose of intravenous calcitriol according to PTH levels. <i>Kidney Int. Suppl<\/i>., S79-S82.","DOI":"10.1046\/j.1523-1755.63.s85.19.x"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg513"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Shurtz-Swirski, R., Shkolnik, T. &amp; Shasha, S.M. (1995) Parathyroid hormone and the cellular immune system. <i>Nephron<\/i>, <b>70<\/b>, 21-24.","DOI":"10.1159\/000188538"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Staeva-Vieira, T.P. &amp; Freedman, L.P. (2002) 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. <i>J. Immunol<\/i>., <b>168<\/b>, 1181-1189.","DOI":"10.4049\/jimmunol.168.3.1181"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Tarcin, O., Yavuz, D.G., Ozben, B., Telli, A., Ogunc, A.V., Yuksel, M., Toprak, A., Yazici, D., Sancak, S., Deyneli, O. &amp; Akalin, S. (2009) Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. <i>J. Clin. Endocrinol. Metab<\/i>., <b>94<\/b>, 4023-4030.","DOI":"10.1210\/jc.2008-1212"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.03.020"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001868"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Valdivielso, J.M., Cannata-Andia, J., Coll, B. &amp; Fernandez, E. (2009) A new role for vitamin D receptor activation in chronic kidney disease. <i>Am. J. Physiol. Renal Physiol<\/i>., <b>297<\/b>, F1502- F1509.","DOI":"10.1152\/ajprenal.00130.2009"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/223\/3\/223_3_153\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T10:10:33Z","timestamp":1637316633000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/223\/3\/223_3_153\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.223.153","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}